Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific

K. H. Chen, D. J. Lundy, E. K.W. Toh, C. H. Chen, C. Shih, P. Chen, H. C. Chang, J. J. Lai, P. S. Stayton, A. S. Hoffman, P. C.H. Hsieh

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

This study comprehensively investigates the changing biodistribution of fluorescent-labelled polystyrene latex bead nanoparticles in a mouse model of inflammation. Since inflammation alters systemic circulatory properties, increases vessel permeability and modulates the immune system, we theorised that systemic inflammation would alter nanoparticle distribution within the body. This has implications for prospective nanocarrier-based therapies targeting inflammatory diseases. Low dose lipopolysaccharide (LPS), a bacterial endotoxin, was used to induce an inflammatory response, and 20 nm, 100 nm or 500 nm polystyrene nanoparticles were administered after 16 hours. HPLC analysis was used to accurately quantify nanoparticle retention by each vital organ, and tissue sections revealed the precise locations of nanoparticle deposition within key tissues. During inflammation, nanoparticles of all sizes redistributed, particularly to the marginal zones of the spleen. We found that LPS-induced inflammation induces splenic macrophage polarisation and alters leukocyte uptake of nanoparticles, with size-dependent effects. In addition, spleen vasculature becomes significantly more permeable following LPS treatment. We conclude that systemic inflammation affects nanoparticle distribution by multiple mechanisms, in a size dependent manner.

Original languageEnglish
Pages (from-to)15863-15872
Number of pages10
JournalNanoscale
Volume7
Issue number38
DOIs
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Nanoparticles
Lipopolysaccharides
Polystyrenes
Tissue
Macrophages
Immune system
Latexes
Endotoxins
Polarization

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Chen, K. H., Lundy, D. J., Toh, E. K. W., Chen, C. H., Shih, C., Chen, P., ... Hsieh, P. C. H. (2015). Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific. Nanoscale, 7(38), 15863-15872. https://doi.org/10.1039/c5nr03626g

Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific. / Chen, K. H.; Lundy, D. J.; Toh, E. K.W.; Chen, C. H.; Shih, C.; Chen, P.; Chang, H. C.; Lai, J. J.; Stayton, P. S.; Hoffman, A. S.; Hsieh, P. C.H.

In: Nanoscale, Vol. 7, No. 38, 01.01.2015, p. 15863-15872.

Research output: Contribution to journalArticle

Chen, KH, Lundy, DJ, Toh, EKW, Chen, CH, Shih, C, Chen, P, Chang, HC, Lai, JJ, Stayton, PS, Hoffman, AS & Hsieh, PCH 2015, 'Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific', Nanoscale, vol. 7, no. 38, pp. 15863-15872. https://doi.org/10.1039/c5nr03626g
Chen, K. H. ; Lundy, D. J. ; Toh, E. K.W. ; Chen, C. H. ; Shih, C. ; Chen, P. ; Chang, H. C. ; Lai, J. J. ; Stayton, P. S. ; Hoffman, A. S. ; Hsieh, P. C.H. / Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific. In: Nanoscale. 2015 ; Vol. 7, No. 38. pp. 15863-15872.
@article{98770f8344ae4553b86c286a3e3c9c62,
title = "Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific",
abstract = "This study comprehensively investigates the changing biodistribution of fluorescent-labelled polystyrene latex bead nanoparticles in a mouse model of inflammation. Since inflammation alters systemic circulatory properties, increases vessel permeability and modulates the immune system, we theorised that systemic inflammation would alter nanoparticle distribution within the body. This has implications for prospective nanocarrier-based therapies targeting inflammatory diseases. Low dose lipopolysaccharide (LPS), a bacterial endotoxin, was used to induce an inflammatory response, and 20 nm, 100 nm or 500 nm polystyrene nanoparticles were administered after 16 hours. HPLC analysis was used to accurately quantify nanoparticle retention by each vital organ, and tissue sections revealed the precise locations of nanoparticle deposition within key tissues. During inflammation, nanoparticles of all sizes redistributed, particularly to the marginal zones of the spleen. We found that LPS-induced inflammation induces splenic macrophage polarisation and alters leukocyte uptake of nanoparticles, with size-dependent effects. In addition, spleen vasculature becomes significantly more permeable following LPS treatment. We conclude that systemic inflammation affects nanoparticle distribution by multiple mechanisms, in a size dependent manner.",
author = "Chen, {K. H.} and Lundy, {D. J.} and Toh, {E. K.W.} and Chen, {C. H.} and C. Shih and P. Chen and Chang, {H. C.} and Lai, {J. J.} and Stayton, {P. S.} and Hoffman, {A. S.} and Hsieh, {P. C.H.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1039/c5nr03626g",
language = "English",
volume = "7",
pages = "15863--15872",
journal = "Nanoscale",
issn = "2040-3364",
publisher = "Royal Society of Chemistry",
number = "38",

}

TY - JOUR

T1 - Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific

AU - Chen, K. H.

AU - Lundy, D. J.

AU - Toh, E. K.W.

AU - Chen, C. H.

AU - Shih, C.

AU - Chen, P.

AU - Chang, H. C.

AU - Lai, J. J.

AU - Stayton, P. S.

AU - Hoffman, A. S.

AU - Hsieh, P. C.H.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - This study comprehensively investigates the changing biodistribution of fluorescent-labelled polystyrene latex bead nanoparticles in a mouse model of inflammation. Since inflammation alters systemic circulatory properties, increases vessel permeability and modulates the immune system, we theorised that systemic inflammation would alter nanoparticle distribution within the body. This has implications for prospective nanocarrier-based therapies targeting inflammatory diseases. Low dose lipopolysaccharide (LPS), a bacterial endotoxin, was used to induce an inflammatory response, and 20 nm, 100 nm or 500 nm polystyrene nanoparticles were administered after 16 hours. HPLC analysis was used to accurately quantify nanoparticle retention by each vital organ, and tissue sections revealed the precise locations of nanoparticle deposition within key tissues. During inflammation, nanoparticles of all sizes redistributed, particularly to the marginal zones of the spleen. We found that LPS-induced inflammation induces splenic macrophage polarisation and alters leukocyte uptake of nanoparticles, with size-dependent effects. In addition, spleen vasculature becomes significantly more permeable following LPS treatment. We conclude that systemic inflammation affects nanoparticle distribution by multiple mechanisms, in a size dependent manner.

AB - This study comprehensively investigates the changing biodistribution of fluorescent-labelled polystyrene latex bead nanoparticles in a mouse model of inflammation. Since inflammation alters systemic circulatory properties, increases vessel permeability and modulates the immune system, we theorised that systemic inflammation would alter nanoparticle distribution within the body. This has implications for prospective nanocarrier-based therapies targeting inflammatory diseases. Low dose lipopolysaccharide (LPS), a bacterial endotoxin, was used to induce an inflammatory response, and 20 nm, 100 nm or 500 nm polystyrene nanoparticles were administered after 16 hours. HPLC analysis was used to accurately quantify nanoparticle retention by each vital organ, and tissue sections revealed the precise locations of nanoparticle deposition within key tissues. During inflammation, nanoparticles of all sizes redistributed, particularly to the marginal zones of the spleen. We found that LPS-induced inflammation induces splenic macrophage polarisation and alters leukocyte uptake of nanoparticles, with size-dependent effects. In addition, spleen vasculature becomes significantly more permeable following LPS treatment. We conclude that systemic inflammation affects nanoparticle distribution by multiple mechanisms, in a size dependent manner.

UR - http://www.scopus.com/inward/record.url?scp=84942627157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942627157&partnerID=8YFLogxK

U2 - 10.1039/c5nr03626g

DO - 10.1039/c5nr03626g

M3 - Article

VL - 7

SP - 15863

EP - 15872

JO - Nanoscale

JF - Nanoscale

SN - 2040-3364

IS - 38

ER -